These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31795761)

  • 1. Sex differences in hypertrophic cardiomyopathy: Time to tailor risk stratification and therapy?
    Constantine A; Dimopoulos K; Rafiq I; Vazir A
    Eur J Prev Cardiol; 2020 Nov; 27(17):1816-1818. PubMed ID: 31795761
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.
    Jacoby DL; DePasquale EC; McKenna WJ
    CMAJ; 2013 Feb; 185(2):127-34. PubMed ID: 23109605
    [No Abstract]   [Full Text] [Related]  

  • 3. Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
    Saberi S; Day SM
    Circulation; 2018 Jan; 137(5):419-421. PubMed ID: 29378753
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.
    Wang RS; Rowin EJ; Maron BJ; Maron MS; Maron BA
    Cardiovasc Res; 2023 May; 119(3):e125-e127. PubMed ID: 37129987
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death].
    McKenna WJ; Monserrat Iglesias L
    Rev Esp Cardiol; 2000 Jan; 53(1):123-30. PubMed ID: 10701329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misconceptions and Facts About Hypertrophic Cardiomyopathy.
    Argulian E; Sherrid MV; Messerli FH
    Am J Med; 2016 Feb; 129(2):148-52. PubMed ID: 26299316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in understanding hypertrophic cardiomyopathy.
    Mohiddin S; Fananapazir L
    Hosp Pract (1995); 2001 May; 36(5):23-5, 29-30, 33-6. PubMed ID: 11361156
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophic obstructive cardiomyopathy.
    Veselka J; Anavekar NS; Charron P
    Lancet; 2017 Mar; 389(10075):1253-1267. PubMed ID: 27912983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
    Dohadwala M; Link MS
    Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED
    J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy.
    Shah M
    Cardiol Young; 2017 Jan; 27(S1):S25-S30. PubMed ID: 28084957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extreme hypertrophic cardiomyopathy.
    Maron BJ; Casey SA; Almquist AK
    Heart; 2004 Jan; 90(1):24. PubMed ID: 14676234
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 16. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
    Christiaans I; Wilde AA
    Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.
    McKenna WJ; Behr ER
    Heart; 2002 Feb; 87(2):169-76. PubMed ID: 11796562
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

  • 20. State-of-the-art management of hypertrophic cardiomyopathy in children.
    Berger S; Dhala A; Dearani JA
    Cardiol Young; 2009 Nov; 19 Suppl 2():66-73. PubMed ID: 19857352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.